ARC Clinical Research is currently enrolling participants in a trial for a pediatric chickenpox vaccine.
Pediatric chickenpox vaccine trial
The trial is studying an investigational vaccine to help prevent chickenpox in 12-15 month olds.
This clinical trial is a carefully designed scientific evaluation of an investigational vaccine. Strict safety and regulatory procedures have been put in place to ensure your child's safety. Throughout the study, your child will be closely monitored by a team of local doctors and nurses.
Who can participate?
We are looking for children, 12-15 months of age, in good health, and who have received the first three doses (primary series) of a pneumococcal conjugate vaccine (PCV13).
What to expect
- The clinical study will last six months.
- Three clinic visits at ARC Kelly Lane in Pflugerville.
- Health evaluation at each appointment by our research nurse and physician.
- Children who participate will also receive three other approved vaccines that are part of routine vaccination schedules.
- No cost for study-related care and evaluations.
- Compensation for your time and travel.
- Stop any time.
How to enroll in the clinical study
ARC Clinical Research looks at new ways to prevent, detect, or treat diseases that affect our community. Volunteers in research studies — people just like you — are a critical link in making these discoveries possible.
Learn more about the chickenpox vaccine trial. Call 512-225-5931 to enroll.